Evidence map›Paper›PMID 40284032›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Synthesis and Neurotropic Activity of New 5-Piperazinopyrazolo[3,4-

Samvel N Sirakanyan, Elmira K Hakobyan, Athina Geronikaki, Domenico Spinelli, Anthi Petrou, Victor G Kartsev, Hasmik A Yegoryan, Hasmik V Jughetsyan, Mariam E Manukyan, Ruzanna G Paronikyan and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samvel N SirakanyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.ORCID 0000-0002-6056-1446
Elmira K HakobyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.
Athina GeronikakiDepartment of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0001-9894-7777
Domenico SpinelliDipartimento di Chimica G. Ciamician, Alma Mater Studiorum-Università di Bologna, Via F. Selmi 2, 40126 Bologna, Italy.
Anthi PetrouDepartment of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Victor G KartsevInterBioScreen, Moscow 119019, Russia.
Hasmik A YegoryanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.
Hasmik V JughetsyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.
Mariam E ManukyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.
Ruzanna G ParonikyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.
Tatevik A AraqelyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.
Anush A HovakimyanScientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Yerevan 0014, Armenia.

Funding

Science Committee of RA 21AG-1D036
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

docking studiesisoxazolo[5,4-c]-2,7-naphthyridinesneurotropic activitypyrazolo[3,4-c]-2,7-naphthyridinespyrimido[1′,2′:1,5]pyrazolo[3,4-c]-2,7-naphthyridines

Identifiers

PMID40284032
PMCPMC12030261

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.